TP53 and hepatocellular carcinoma: Recent studies have unveiled TB’s anti-proliferative, pro-apoptotic, and tumor-suppressive impacts on HCC cells by employing a multi-targeting mechanism that engages the p53 and JNK signaling pathways (43).